Live Action alleges "reckless distribution" of the abortion drug mifepristone, urging the Trump administration to suspend its ...
Looser regulations around consumer-grade wearable devices could be a "path to ROI" for health systems—or a "double-edged ...
The FDA has authorized urcosimod 0.05% for single-patient expanded access, or compassionate use, in a patient with ...
The initiative could tackle the first-mover disadvantage some CDMOs believe deters early customers, but leaders at companies ...
The FDA released a draft guidance document that provides a regulatory framework for sponsors to utilize minimal residual ...
The FDA has granted breakthrough therapy designation to Novartis’ ianalumab for Sjögren’s disease, according to a press release from the manufacturer.In its statement, Novartis said it plans to submit ...
ImmunityBio stock rose 19.8% after FDA meeting on ANKTIVA bladder cancer treatment. Company to submit additional data within ...
A consumer pricing framework for 'Cheapest Compounded Semaglutide,' 'Cheapest Compounded Semaglutide Online,' and 'Cheapest ...
After 35 years of consistent pain, Allan Byamukama became one of the few individuals in the world cured of sickle cell disease through gene therapy. Born in Uganda and diagnosed with ...
The U.S. Food and Drug Administration (FDA) has accepted a new drug application for gedatolisib in hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-), PIK3CA ...
Townsmen dressed in brown trousers and a black T-shirt stand as the sunlight litters the communal town of Vetesu in Lofa ...
Gedatolisib's NDA for advanced breast cancer treatment has been accepted by the FDA, with a priority review and a PDUFA date ...